title: Increased erythropoietin level and reticulocyte count during arsenic trioxide therapy.
authors.forename: T
authors.initials: T
authors.lastname: Kajiguchi
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
authors.forename: M
authors.initials: M
authors.lastname: Sawa
authors.forename: N
authors.initials: N
authors.lastname: Emi
authors.forename: T
authors.initials: T
authors.lastname: Naoe
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage* / Q000009:adverse effects; D004921:Erythropoietin / Q000097:blood*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage* / Q000009:adverse effects; D017701:Reticulocyte Count
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D004921:Erythropoietin; D000077237:Arsenic Trioxide